Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Frankfurt - Delayed Quote EUR

NanoViricides, Inc. (NV3P.F)

Compare
1.1300
-0.1500
(-11.72%)
As of 8:12:01 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
9,526.6490
8,516.1110
8,943.4680
8,113.5990
8,744.1060
Operating Income
-9,526.6490
-8,516.1110
-8,943.4680
-8,113.5990
-8,744.1060
Net Non Operating Interest Income Expense
161.8840
221.9650
354.8950
6.7360
-76.0570
Other Income Expense
--
--
--
--
-2.0260
Pretax Income
-9,364.7650
-8,294.1460
-8,588.5730
-8,106.8630
-8,822.1890
Net Income Common Stockholders
-9,364.7650
-8,294.1460
-8,588.5730
-8,106.8630
-8,822.1890
Diluted NI Available to Com Stockholders
-9,364.7650
-8,294.1460
-8,588.5730
-8,106.8630
-8,822.1890
Basic EPS
-0.71
-0.70
-0.74
-0.70
-0.81
Diluted EPS
-0.71
-0.70
-0.74
-0.70
-0.81
Basic Average Shares
13,070.9590
11,871.0540
11,626.2200
11,534.6980
10,900.9550
Diluted Average Shares
13,070.9590
11,871.0540
11,626.2200
11,534.6980
10,900.9550
Total Operating Income as Reported
-9,526.6490
-8,516.1110
-8,943.4680
-8,113.5990
-8,744.1060
Total Expenses
9,526.6490
8,516.1110
8,943.4680
8,113.5990
8,744.1060
Net Income from Continuing & Discontinued Operation
-9,364.7650
-8,294.1460
-8,588.5730
-8,106.8630
-8,822.1890
Normalized Income
-9,364.7650
-8,294.1460
-8,588.5730
-8,106.8630
-8,820.1630
Interest Income
162.0330
271.7730
355.8330
11.8590
9.3480
Interest Expense
0.1490
49.8080
0.9380
5.1230
85.4050
Net Interest Income
161.8840
221.9650
354.8950
6.7360
-76.0570
EBIT
-9,364.6160
-8,244.3380
-8,587.6350
-8,101.7400
-8,736.7840
EBITDA
-8,592.5610
-7,485.3240
-7,840.1060
-7,378.4150
-8,032.2460
Reconciled Depreciation
772.0550
759.0140
747.5290
723.3250
704.5380
Net Income from Continuing Operation Net Minority Interest
-9,364.7650
-8,294.1460
-8,588.5730
-8,106.8630
-8,822.1890
Total Unusual Items Excluding Goodwill
--
--
--
--
-2.0260
Total Unusual Items
--
--
--
--
-2.0260
Normalized EBITDA
-8,592.5610
-7,485.3240
-7,840.1060
-7,378.4150
-8,030.2200
6/30/2021 - 7/10/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MAGLE.ST Magle Chemoswed Holding AB (publ)
32.40
0.00%
 
MOC.WA Molecure S.A.
9.00
+1.69%
 
HQ1.MU Oruka Therapeutics Inc. R
10.30
-2.83%
 
RGO.DU Regeneron Pharmaceuticals Inc
684.00
+1.33%
 
BSSP Baseline Productions, Inc.
0.0001
0.00%
 
CHOSA.ST CHOSA Oncology AB
0.9000
+28.57%
 
PH4.F CStone Pharmaceuticals
0.4320
+1.89%
 
BXPHF Botanix Pharmaceuticals Limited
0.2950
0.00%
 
ARDX.MX Ardelyx, Inc.
105.50
0.00%
 
GYX.F Futura Medical plc
0.1340
-25.56%